Literature DB >> 19535339

Structural characterization of clusterin-chaperone client protein complexes.

Amy R Wyatt1, Justin J Yerbury, Mark R Wilson.   

Abstract

Clusterin (CLU) is a potent extracellular chaperone that inhibits protein aggregation and precipitation otherwise caused by physical or chemical stresses (e.g. heat, reduction). This action involves CLU forming soluble high molecular weight (HMW) complexes with the client protein. Other than their unquantified large size, the physical characteristics of these complexes were previously unknown. In this study, HMW CLU-citrate synthase (CS), HMW CLU-fibrinogen (FGN), and HMW CLU-glutathione S-transferase (GST) complexes were generated in vitro, and their structures studied using size exclusion chromatography (SEC), ELISA, SDS-PAGE, dynamic light scattering (DLS), bisANS fluorescence, and circular dichroism spectrophotometry (CD). Densitometry of Coomassie Blue-stained SDS-PAGE gels indicated that all three HMW CLU-client protein complexes had an approximate mass ratio of 1:2 (CLU:client protein). SEC indicated that all three clients formed complexes with CLU>or=4x10(7) Da; however, DLS estimated HMW CLU-FGN to have a diameter of 108.57+/-18.09 nm, while HMW CLU-CS and HMW CLU-GST were smaller with estimated diameters of 51.06+/-6.87 nm and 52.61+/-7.71 nm, respectively. Measurements of bisANS fluorescence suggest that the chaperone action of CLU involves preventing the exposure to aqueous solvent of hydrophobic regions that are normally exposed by the client protein during heat-induced unfolding. CD analysis indicated that, depending on the individual client protein, CLU may interact with a variety of intermediates on protein unfolding pathways with different amounts of native secondary structure. In vivo, soluble complexes like those studied here are likely to serve as vehicles to dispose of otherwise dangerous aggregation-prone misfolded extracellular proteins.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19535339      PMCID: PMC2755916          DOI: 10.1074/jbc.M109.033688

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  39 in total

Review 1.  Protein misfolding and disease; protein refolding and therapy.

Authors:  C Soto
Journal:  FEBS Lett       Date:  2001-06-08       Impact factor: 4.124

Review 2.  From the cradle to the grave: molecular chaperones that may choose between folding and degradation.

Authors:  J Höhfeld; D M Cyr; C Patterson
Journal:  EMBO Rep       Date:  2001-10       Impact factor: 8.807

3.  Drusen proteome analysis: an approach to the etiology of age-related macular degeneration.

Authors:  John W Crabb; Masaru Miyagi; Xiaorong Gu; Karen Shadrach; Karen A West; Hirokazu Sakaguchi; Motohiro Kamei; Azeem Hasan; Lin Yan; Mary E Rayborn; Robert G Salomon; Joe G Hollyfield
Journal:  Proc Natl Acad Sci U S A       Date:  2002-10-21       Impact factor: 11.205

4.  Increasing temperature accelerates protein unfolding without changing the pathway of unfolding.

Authors:  Ryan Day; Brian J Bennion; Sihyun Ham; Valerie Daggett
Journal:  J Mol Biol       Date:  2002-09-06       Impact factor: 5.469

5.  Drug fever.

Authors:  K L Kumar; J B Reuler
Journal:  West J Med       Date:  1986-06

6.  Protein damage and degradation by oxygen radicals. III. Modification of secondary and tertiary structure.

Authors:  K J Davies; M E Delsignore
Journal:  J Biol Chem       Date:  1987-07-15       Impact factor: 5.157

7.  Evidence that clusterin has discrete chaperone and ligand binding sites.

Authors:  Johnathon N Lakins; Stephen Poon; Simon B Easterbrook-Smith; John A Carver; Martin P R Tenniswood; Mark R Wilson
Journal:  Biochemistry       Date:  2002-01-08       Impact factor: 3.162

8.  Mildly acidic pH activates the extracellular molecular chaperone clusterin.

Authors:  Stephen Poon; Mark S Rybchyn; Simon B Easterbrook-Smith; John A Carver; Greg J Pankhurst; Mark R Wilson
Journal:  J Biol Chem       Date:  2002-08-09       Impact factor: 5.157

9.  Clusterin/apolipoprotein J is associated with cortical Lewy bodies: immunohistochemical study in cases with alpha-synucleinopathies.

Authors:  Kensuke Sasaki; Katsumi Doh-ura; Yoshinobu Wakisaka; Toru Iwaki
Journal:  Acta Neuropathol       Date:  2002-05-09       Impact factor: 17.088

10.  Measurement of protein using bicinchoninic acid.

Authors:  P K Smith; R I Krohn; G T Hermanson; A K Mallia; F H Gartner; M D Provenzano; E K Fujimoto; N M Goeke; B J Olson; D C Klenk
Journal:  Anal Biochem       Date:  1985-10       Impact factor: 3.365

View more
  35 in total

1.  Serum albumin prevents protein aggregation and amyloid formation and retains chaperone-like activity in the presence of physiological ligands.

Authors:  Thomas E Finn; Andrea C Nunez; Margaret Sunde; Simon B Easterbrook-Smith
Journal:  J Biol Chem       Date:  2012-05-01       Impact factor: 5.157

2.  CRM1 protein-mediated regulation of nuclear clusterin (nCLU), an ionizing radiation-stimulated, Bax-dependent pro-death factor.

Authors:  Konstantin S Leskov; Shinako Araki; John-Paul Lavik; Jose A Gomez; Vivian Gama; Efstathios S Gonos; Ioannis P Trougakos; Shigemi Matsuyama; David A Boothman
Journal:  J Biol Chem       Date:  2011-09-27       Impact factor: 5.157

3.  The chaperone protein clusterin may serve as a cerebrospinal fluid biomarker for chronic spinal cord disorders in the dog.

Authors:  Intan N F Shafie; Mark McLaughlin; Richard Burchmore; Mary Ann A Lim; Paul Montague; Pamela E J Johnston; Jacques Penderis; Thomas J Anderson
Journal:  Cell Stress Chaperones       Date:  2013-08-29       Impact factor: 3.667

Review 4.  Amyloid β Protein and Alzheimer's Disease: When Computer Simulations Complement Experimental Studies.

Authors:  Jessica Nasica-Labouze; Phuong H Nguyen; Fabio Sterpone; Olivia Berthoumieu; Nicolae-Viorel Buchete; Sébastien Coté; Alfonso De Simone; Andrew J Doig; Peter Faller; Angel Garcia; Alessandro Laio; Mai Suan Li; Simone Melchionna; Normand Mousseau; Yuguang Mu; Anant Paravastu; Samuela Pasquali; David J Rosenman; Birgit Strodel; Bogdan Tarus; John H Viles; Tong Zhang; Chunyu Wang; Philippe Derreumaux
Journal:  Chem Rev       Date:  2015-03-19       Impact factor: 60.622

5.  Amorphous protein aggregates stimulate plasminogen activation, leading to release of cytotoxic fragments that are clients for extracellular chaperones.

Authors:  Patrick Constantinescu; Rebecca A Brown; Amy R Wyatt; Marie Ranson; Mark R Wilson
Journal:  J Biol Chem       Date:  2017-07-14       Impact factor: 5.157

6.  Interaction of clusterin and matrix metalloproteinase-9 and its implication for epithelial homeostasis and inflammation.

Authors:  Shinwu Jeong; Dolena R Ledee; Gabriel M Gordon; Tatsuo Itakura; Nitin Patel; Aaron Martin; M Elizabeth Fini
Journal:  Am J Pathol       Date:  2012-03-20       Impact factor: 4.307

7.  DIPPER, a spatiotemporal proteomics atlas of human intervertebral discs for exploring ageing and degeneration dynamics.

Authors:  Vivian Tam; Peikai Chen; Anita Yee; Nestor Solis; Theo Klein; Mateusz Kudelko; Rakesh Sharma; Wilson Cw Chan; Christopher M Overall; Lisbet Haglund; Pak C Sham; Kathryn Song Eng Cheah; Danny Chan
Journal:  Elife       Date:  2020-12-31       Impact factor: 8.140

8.  Identification of human plasma proteins as major clients for the extracellular chaperone clusterin.

Authors:  Amy R Wyatt; Mark R Wilson
Journal:  J Biol Chem       Date:  2009-12-07       Impact factor: 5.157

9.  Evidence for a functional role of the molecular chaperone clusterin in amyloidotic cardiomyopathy.

Authors:  Michael J Greene; Flora Sam; Pamela T Soo Hoo; Rupesh S Patel; David C Seldin; Lawreen H Connors
Journal:  Am J Pathol       Date:  2010-12-23       Impact factor: 4.307

10.  Development of AD-Like Pathology in Skeletal Muscle.

Authors:  X Chen; N M Miller; Z Afghah; J D Geiger
Journal:  J Parkinsons Dis Alzheimers Dis       Date:  2019-04-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.